EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis

Viviana Scalavino iD, Emanuele Piccinno iD, Anna Maria Valentini iD, Nicolò Schena, Raffaele Armentano iD, Gianluigi Giannelli iD, Grazia Serino iD

Cells · 2023

DOI: 10.3390/cells12172184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Viviana Scalavino und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, BA, Italy. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, MicroRNAs. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammasomes are multiprotein complexes expressed by immune cells in response to distinct stimuli that trigger inflammatory responses and the release of pro-inflammatory cytokines. Evidence suggests a different role of inflammasome NLRP3 in IBD. NLRP3 inflammasome activation can be controlled by post-translational modifications such as ubiquitination through BRCC3. The aim of this study was to investigate the effect of miR-369-3p on the expression and activation of NLRP3 inflammasomes via BRCC3 regulation. After bioinformatics prediction of Brcc3 as a gene target of miR-369-3p, in vitro, we validated its modulation in bone marrow-derived macrophages (BMDM). The increase in miR-369-3p significantly reduced BRCC3 gene and protein expression. This modulation, in turn, reduced the expression of NLRP3 and blocked the recruitment of ASC adaptor protein by NLRP3. As a result, miR-369-3p reduced the activity of Caspase-1 by the inflammasome, decreasing the cleavage of pro-IL-1β and pro-IL-18. These results support a novel mechanism that seems to act on post-translational modification of NLRP3 inflammasome activation by BRCC3. This may be an interesting new target in the personalized treatment of inflammatory disorders, including IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesMicroRNAsHumansInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAdaptor Proteins, Signal TransducingDeubiquitinating Enzymes

Stichwörter der Autor:innen

BRCC3NLRP3inflammasomemiR-369-3pmicroRNA

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAdaptor Proteins, Signal TransducingMicroRNAsBRCC3 protein, humanDeubiquitinating EnzymesMIRN369 microRNA, human

Autor:innen und Institutionen

  • National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, 70013 Castellana Grotte, BA, Italy.

ORCID-Profile: Viviana Scalavino, Emanuele Piccinno, Anna Maria Valentini, Raffaele Armentano, Gianluigi Giannelli, Grazia Serino

Förderung

  • Italian Ministry of Health

Zitieren

APA

Scalavino, V., Piccinno, E., Valentini, A. M., Schena, N., Armentano, R., Giannelli, G., & Serino, G. (2023). miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis. Cells. https://doi.org/10.3390/cells12172184

Vancouver

Scalavino V, Piccinno E, Valentini AM, Schena N, Armentano R, Giannelli G, et al. miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis. Cells. 2023. doi:10.3390/cells12172184

BibTeX
@article{Scalavino2023,
  author = {Scalavino, Viviana and Piccinno, Emanuele and Valentini, Anna Maria and Schena, Nicolò and Armentano, Raffaele and Giannelli, Gianluigi and Serino, Grazia},
  title = {miR-369-3p Modulates Intestinal Inflammatory Response via BRCC3/NLRP3 Inflammasome Axis},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12172184}
}
Kostenlos starten →